S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
Free Trial

Dr. Reddy's Laboratories (RDY) Earnings Date, Estimates & Call Transcripts

→ Special FREE offer on stock hotsheets (From DTI) (Ad)
Free RDY Stock Alerts
$71.09
+0.18 (+0.25%)
(As of 11:45 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 8Estimated
Actual EPS
(Jan. 31)
$0.99 Beat By $0.11
Consensus EPS
(Jan. 31)
$0.88
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RDY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RDY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Dr. Reddy's Laboratories Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241$0.71$0.71$0.71
Q2 20241$0.88$0.88$0.88
Q3 20241$0.87$0.87$0.87
Q4 20241$0.86$0.86$0.86
FY 20244$3.32$3.32$3.32
Q1 20251$1.10$1.10$1.10
Q2 20251$0.99$0.99$0.99
Q3 20251$1.00$1.00$1.00
Q4 20251$1.00$1.00$1.00
FY 20254$4.09$4.09$4.09
Q1 20261$1.02$1.02$1.02
Q2 20261$1.02$1.02$1.02
Q3 20261$1.05$1.05$1.05

RDY Earnings Date and Information

Dr. Reddy's Laboratories last issued its earnings data on January 31st, 2024. The reported $0.99 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.88 by $0.11. The business earned $867 million during the quarter, compared to the consensus estimate of $827.81 million. Dr. Reddy's Laboratories has generated $3.79 earnings per share over the last year ($3.79 diluted earnings per share) and currently has a price-to-earnings ratio of 18.8. Earnings for Dr. Reddy's Laboratories are expected to grow by 4.04% in the coming year, from $3.96 to $4.12 per share. Dr. Reddy's Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.

Dr. Reddy's Laboratories Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Estimated)		------- 
1/31/2024Q4 2023$0.88$0.99+$0.11$0.99$827.81 million$867.00 million    
10/27/2023Q2 2024$0.88$1.07+$0.19$1.07$825.94 million$832.16 million
7/26/2023Q1 2024$0.71$1.03+$0.32$1.03$790.67 million$820.20 million
5/10/2023Q4 2023$0.57$0.70+$0.13$0.70$763.37 million$766.00 million
1/25/2023Q3 2023$0.60$0.91+$0.31$0.91$769.25 million$818.00 million
10/28/2022Q2 2023$0.59$0.82+$0.23$0.82$763.28 million$775.00 million
7/28/2022Q1 2023$0.58$0.90+$0.32$0.90$767.00 million$660.00 million
5/19/2022Q4 2022-$0.53+$0.53$0.99-$717.00 million
1/28/2022Q3 2022-$0.57+$0.57$0.57-$715.00 million
10/29/2021Q3 2021$0.56$0.80+$0.24$0.80-$777.00 million
7/27/2021Q2 2021$0.55$0.46($0.09)$0.46$685.22 million$662.00 million
5/13/2021Q1 2021$0.51$0.46($0.05)$0.46-$646.00 million  

Dr. Reddy's Laboratories Earnings - Frequently Asked Questions

When is Dr. Reddy's Laboratories's earnings date?

Dr. Reddy's Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on RDY's earnings history.

Did Dr. Reddy's Laboratories beat their earnings estimates last quarter?

In the previous quarter, Dr. Reddy's Laboratories (NYSE:RDY) reported $0.99 earnings per share (EPS) to beat the analysts' consensus estimate of $0.88 by $0.11. Learn more on analysts' earnings estimate vs. RDY's actual earnings.

How can I listen to Dr. Reddy's Laboratories's earnings conference call?

The conference call for Dr. Reddy's Laboratories's latest earnings report can be listened to online. Listen to Conference Call

How can I read Dr. Reddy's Laboratories's conference call transcript?

The conference call transcript for Dr. Reddy's Laboratories's latest earnings report can be read online. Read Transcript

How much revenue does Dr. Reddy's Laboratories generate each year?

Dr. Reddy's Laboratories (NYSE:RDY) has a recorded annual revenue of $2.99 billion.

How much profit does Dr. Reddy's Laboratories generate each year?

Dr. Reddy's Laboratories (NYSE:RDY) has a recorded net income of $548 million. RDY has generated $3.79 earnings per share over the last four quarters.

What is Dr. Reddy's Laboratories's price-to-earnings ratio?

Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 18.76 and a forward price-to-earnings ratio of 17.95. The price/earnings-to-growth ratio is 1.78.

What is Dr. Reddy's Laboratories's EPS forecast for next year?

Dr. Reddy's Laboratories's earnings are expected to grow from $3.96 per share to $4.12 per share in the next year, which is a 4.04% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:RDY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes